These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India. Mondal D, Julka PK, Sharma DN, Jana M, Laviraj MA, Deo SV, Roy S, Guleria R, Rath GK. J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538 [Abstract] [Full Text] [Related]
3. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge. Zwicker F, Hoefel S, Kirchner C, Huber PE, Debus J, Schempp M. Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396 [Abstract] [Full Text] [Related]
4. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial. Jin K, Luo J, Yu X, Guo X. Radiat Oncol; 2024 May 27; 19(1):62. PubMed ID: 38802888 [Abstract] [Full Text] [Related]
5. Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients. Bao YQ, Yu TH, Huang W, Mao QF, Tu GJ, Li B, Yi A, Li JG, Rao J, Zhang HW, Jiang CL. Breast Cancer; 2024 Jul 27; 31(4):726-734. PubMed ID: 38705942 [Abstract] [Full Text] [Related]
6. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients. Cante D, Rosa La Porta M, Casanova-Borca V, Sciacero P, Girelli G, Pasquino M, Franco P, Ozzello F. Breast J; 2011 Jul 27; 17(6):586-93. PubMed ID: 21951485 [Abstract] [Full Text] [Related]
7. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. King MT, Link EK, Whelan TJ, Olivotto IA, Kunkler I, Westenberg AH, Gruber G, Schofield P, Chua BH, BIG 3-07/TROG 07.01 trial investigators. Lancet Oncol; 2020 May 27; 21(5):685-698. PubMed ID: 32203696 [Abstract] [Full Text] [Related]
9. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. Scorsetti M, Alongi F, Fogliata A, Pentimalli S, Navarria P, Lobefalo F, Garcia-Etienne C, Clivio A, Cozzi L, Mancosu P, Nicolini G, Vanetti E, Eboli M, Rossetti C, Rubino A, Sagona A, Arcangeli S, Gatzemeier W, Masci G, Torrisi R, Testori A, Alloisio M, Santoro A, Tinterri C. Radiat Oncol; 2012 Aug 28; 7():145. PubMed ID: 22929062 [Abstract] [Full Text] [Related]
10. A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose. Hong Z, Yang Z, Mei X, Li P, Bao C, Wang Z, Cai X, Ming X, Wang W, Guo X, Yu X, Zhang Q. Radiat Oncol; 2023 Mar 23; 18(1):56. PubMed ID: 36959653 [Abstract] [Full Text] [Related]
11. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature. De Rose F, Fogliata A, Franceschini D, Iftode C, Navarria P, Comito T, Franzese C, Fernandes B, Masci G, Torrisi R, Tinterri C, Testori A, Santoro A, Scorsetti M. Breast; 2018 Dec 23; 42():31-37. PubMed ID: 30149235 [Abstract] [Full Text] [Related]
12. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result. Lee HH, Hou MF, Chuang HY, Huang MY, Tsuei LP, Chen FM, Ou-Yang F, Huang CJ. Breast; 2015 Oct 23; 24(5):656-60. PubMed ID: 26371691 [Abstract] [Full Text] [Related]
13. One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT. Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Bloomfield DJ, Chan C, Cleator S, Coles CE, Donovan E, Fleming H, Glynn D, Goodman A, Griffin S, Hopwood P, Kirby AM, Kirwan CC, Nabi Z, Patel J, Sawyer E, Somaiah N, Syndikus I, Venables K, Yarnold JR, Bliss JM, FAST-Forward Trial Management Group. Health Technol Assess; 2023 Nov 23; 27(25):1-176. PubMed ID: 37991196 [Abstract] [Full Text] [Related]
14. A comparative study on hypofractionated whole-breast irradiation with sequential or simultaneous integrated boost on different positions after breast-conserving surgery. Yu T, Li Y, Sun T, Xu M, Wang W, Shao Q, Zhang Y, Li J, Yu J. Sci Rep; 2021 Sep 09; 11(1):18017. PubMed ID: 34504253 [Abstract] [Full Text] [Related]
17. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity. Linares I, Tovar MI, Zurita M, Guerrero R, Expósito M, Del Moral R. Clin Breast Cancer; 2016 Aug 09; 16(4):262-8. PubMed ID: 26454613 [Abstract] [Full Text] [Related]
18. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials. Pfaffendorf C, Vonthein R, Krockenberger-Ziegler K, Dellas K, Schreiber A, Uhlemann D, Dinges S, Würschmidt F, Andreas P, Weinstrauch E, Eilf K, Rades D, Höller U, Combs SE, Kazmierczak R, Fehlauer F, Schreck U, Zimmer J, Dunst J, Krug D. Breast; 2022 Aug 09; 64():136-142. PubMed ID: 35691249 [Abstract] [Full Text] [Related]
19. Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis. Oses G, Barreto TD, Cases C, Muñoz-Guglielmetti D, Antelo G, Mollà M. Clin Transl Oncol; 2023 Aug 09; 25(8):2419-2426. PubMed ID: 36947361 [Abstract] [Full Text] [Related]
20. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity. Deantonio L, Gambaro G, Beldì D, Masini L, Tunesi S, Magnani C, Krengli M. Radiat Oncol; 2010 Nov 23; 5():112. PubMed ID: 21092288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]